ITRO Co-Chairs:
Josh Yamada, MSKCC NY, USA
Michael Jackson, POWH, Australia
Joseph Bucci, SG CCC, Australia
Friday, 17th February
7:45-7:50 Welcome Josh Yamada and Anatoly Rozenfeld
7:50-8:00 Opening Prof David Currow , DVC (Health and Sustainable Futures), UOW
Prostate
8:00-9:00 Michael Zelefsky, MSKCC, NY, USA
Talk 1:
Novel Approaches for Maximizing Tumour Control and Minimizing Toxicity with Prostate SBRT
Talk 2:
How Genomic Classifiers Can Modify and Optimize our Management of Localized Prostate Cancer
9:00-9:30 Prostate Tumour Board
M.Zelefsky, MSKCC, NY, USA; M. Jackson, POWH, Australia;
J.Bucci, SGCCC, Australia
9:30-10:00 Coffee break
GI
10:00-11:00 Laura Dawson, The Princess Margaret Cancer Centre, Canada
Talk 1:
Hepatocellular Carcinoma SBRT – a standard of care
Talk 2:
Searching for biomarkers in upper GI cancers
11:00-11:30 GI Tumour Board
L.Dawson, The Princess Margaret Cancer Centre, Canada
A.Koong, MD Anderson Cancer Center, USA
Australia (TBA)
CNS
11:30-12:30 Igor Barani, Barrow Neurological Institute, USA
Talk 1: TBA
Talk 2: How radiomics approaches can be “practically” used in the management and post-treatment monitoring of glioblastoma
12:30-13:30 Lunch
13:30-14:00 CNS Tumour Board
I.Barani, Barrow Neurological Institute, USA
T.Chan, Lerner Research Institute, USA
Ben Chua, Genesis Care, Australia
Lung
14:00-15:00 Andrea Rimner, MSKCC, NY, USA
Talk 1:
Lung /Integration of radiation therapy and immunotherapy in stage I-III non-small cell lung cancer
Talk 2:
The role of cfDNA and molecular markers to select lung cancer patients for radiotherapy
15:00-15:30 Coffee break
15:30-16:00 Lung Tumour Board
A.Rimner, MSKCC, NY, USA
S.Rosenberg, Moffitt Cancer Center, USA
TBA, Australia
Physics
16:00-16:30 Stefan Both, The University Medical Centre Groningen, Holland
Proton Arc-Back to the future
16:00-16:45 Wolfgang Tome, Montefiore Medical Center, USA
Commissioning and testing of a real time motion adaptive ring gantry based radiotherapy system.
16:45-17:00 Vladimir Feygelman, Moffitt Cancer Centre , USA
Towards automating clinical head and neck treatment planning without sacrificing quality
Special Lecture
17:00-18:00 Timothy Chan, Lerner Research Institute, USA
Radiotherapy and Immunotherapy
Saturday, 18th February
8:00-9:00 Josh Yamada, MSKCC, NY, USA
Salvage Radiation for Spine Metastases Recurrent After Initial SBRT
9:00-9:30 Spine Tumour Board
J.Yamada, MSKCC ,NY, USA
TBA
9:30-10:00 Coffee break
H&N
10:00-11:00 Nancy Lee, MSKCC, NY, USA
Talk 1:
Towards Precision Oncology for Oropharyngeal Carcinoma and Nasopahryngeal Carcinoma
Talk 2:
Lessons learned using biomarker driven de-escalation approach for HPV+ oropharyngeal carcinoma
11:00-11:30 H&N Tumour Board
N.Lee, MSKCC, NY, USA
Baxi, John Flynn Private Hospital, Australia
11:30-12:30 Stephen Rosenberg, Moffitt Cancer Centre, USA
Personalized Cancer Care with MRI Guided Radiotherapy
12:30-13:30 Lunch
13:30-14:30 Albert Koong, MD Anderson Cancer Centre, USA
FLASH Radiotherapy: Ready for Translation into the Clinic?
14:30-14:45 Registrar presentation
14:45-15:00 Eric Fong, POWH, Australia
Adjuvant small field pelvic radiotherapy for high risk early-stage cervical cancer
15:00-15:30 Coffee break
15:30-17:00 Particle Therapy
Carl Rossi, California Protons Cancer Therapy Center, USA
Curtiland Deville, Johns Hopkins Proton Therapy Center, USA
Hiroshi Ishikawa, HIT QST, Japan
Special Lecture
17:00-18:00 Laura Dawson, The Princess Margaret Cancer Centre, Canada
The Future of Radiation Oncology
Closing and MMND ITRO 2025
Josh and Anatoly